These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies. Bibollet-Ruche F; Russell RM; Ding W; Liu W; Li Y; Wagh K; Wrapp D; Habib R; Skelly AN; Roark RS; Sherrill-Mix S; Wang S; Rando J; Lindemuth E; Cruickshank K; Park Y; Baum R; Carey JW; Connell AJ; Li H; Giorgi EE; Song GS; Ding S; Finzi A; Newman A; Hernandez GE; Machiele E; Cain DW; Mansouri K; Lewis MG; Montefiori DC; Wiehe KJ; Alam SM; Teng IT; Kwong PD; Andrabi R; Verkoczy L; Burton DR; Korber BT; Saunders KO; Haynes BF; Edwards RJ; Shaw GM; Hahn BH mBio; 2023 Feb; 14(1):e0337022. PubMed ID: 36629414 [TBL] [Abstract][Full Text] [Related]
8. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope. Joshi VR; Claiborne DT; Pack ML; Power KA; Newman RM; Batorsky R; Bean DJ; Goroff MS; Lingwood D; Seaman MS; Rosenberg E; Allen TM J Virol; 2024 Mar; 98(3):e0172023. PubMed ID: 38412036 [TBL] [Abstract][Full Text] [Related]
9. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies. Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996 [TBL] [Abstract][Full Text] [Related]
10. Near-Pan-neutralizing, Plasma Deconvoluted Antibody N49P6 Mimics Host Receptor CD4 in Its Quaternary Interactions with the HIV-1 Envelope Trimer. Tolbert WD; Nguyen DN; Tehrani ZR; Sajadi MM; Pazgier M mBio; 2021 Aug; 12(4):e0127421. PubMed ID: 34281393 [TBL] [Abstract][Full Text] [Related]
11. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein. van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes. Ditse Z; Muenchhoff M; Adland E; Jooste P; Goulder P; Moore PL; Morris L J Virol; 2018 Sep; 92(17):. PubMed ID: 29950423 [TBL] [Abstract][Full Text] [Related]
13. Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes. Kong R; Louder MK; Wagh K; Bailer RT; deCamp A; Greene K; Gao H; Taft JD; Gazumyan A; Liu C; Nussenzweig MC; Korber B; Montefiori DC; Mascola JR J Virol; 2015 Mar; 89(5):2659-71. PubMed ID: 25520506 [TBL] [Abstract][Full Text] [Related]
14. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335 [TBL] [Abstract][Full Text] [Related]
15. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728 [TBL] [Abstract][Full Text] [Related]
16. Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers. Nyanhete TE; Edwards RJ; LaBranche CC; Mansouri K; Eaton A; Dennison SM; Saunders KO; Goodman D; Janowska K; Spreng RL; Zhang L; Mudrak SV; Hope TJ; Hora B; Bradley T; Georgiev IS; Montefiori DC; Acharya P; Tomaras GD Front Immunol; 2021; 12():670561. PubMed ID: 35003053 [TBL] [Abstract][Full Text] [Related]
17. Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals. Martin F; Marcelino JM; Palladino C; Bártolo I; Tracana S; Moranguinho I; Gonçalves P; Mateus R; Calado R; Borrego P; Leitner T; Clemente S; Taveira N Microbiol Spectr; 2022 Dec; 10(6):e0163422. PubMed ID: 36445130 [TBL] [Abstract][Full Text] [Related]
18. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies. Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842 [TBL] [Abstract][Full Text] [Related]
19. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex. Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711 [TBL] [Abstract][Full Text] [Related]
20. Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses. Berendam SJ; Styles TM; Morgan-Asiedu PK; Tenney D; Kumar A; Obregon-Perko V; Bar KJ; Saunders KO; Santra S; De Paris K; Tomaras GD; Chahroudi A; Permar SR; Amara RR; Fouda GG J Virol; 2021 Jan; 95(3):. PubMed ID: 33177194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]